TAKE-A-LOOK-Clinical Oncology annual meeting

The American Society of Clinical Oncology released a wave of abstracts of
clinical studies on Thursday ahead of its annual meeting. The official meeting,
a premier scientific and medical event in the oncology community, begins on May
30 in Chicago.

For full stories, click within the square brackets:
LATEST STORIES
> Lung cancer patients live longer with Alimta - study [nN15337149]
> Study shows RAD001 froze kidney cancer for a year [nL15695357]
> Onyx drug boosts liver cancer survival [nN15316331]
> Amgen drug has little impact on brain cancer [nN08419268]
> Vitamin D may lower breast cancer risk [nN15294793]
> Amgen says its denosumab combats rare bone tumors [nN08407352]
> Rash most common side effect in Vectibix trials [nN15357761]
> Heart risks high in childhood cancer survivors [nN15343112]
> Herceptin enhances Tykerb for breast cancer - study [nN15290858]
> Avastin improves brain cancer survival [nN15422077]
> Genentech moves up timeline for Avastin trial [nN15358426]
> Eisai says drug active in advanced breast cancer [nT326906]
> Bone drugs helps fight cancer spread -- U.S. report [nN15343293]
> Failed lung cancer drug has breast cancer promise [nN15346451]
> New scans prompt mastectomies for breast patients [nN15327300]
(New York equities desk; 1 646 223 6200)